Immuneering Corp Director Schall Thomas J. Buys 21,645 Shares at $4.67/Share.

martes, 20 de enero de 2026, 9:22 am ET1 min de lectura
IMRX--

Immuneering Corp (IMRX) has recently disclosed that Director Thomas J. Schall has made a notable investment in the company. On January 15, 2026, he purchased 21,645 shares at a price of $4.67 per share.

Immuneering Corp Director Schall Thomas J. Buys 21,645 Shares at $4.67/Share.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios